Pattern of Interleukin-۱۷A and Interleukin-۱β in Migraine Patients

سال انتشار: 1403
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 228

فایل این مقاله در 5 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_JKMU-31-4_007

تاریخ نمایه سازی: 13 آبان 1403

چکیده مقاله:

Background: Migraine is a complex neurological disorder. The precise etiology of migraine is not clear. Many studies have been conducted on the association of the immune system with migraine pathophysiology. Neurogenic inflammation as the main pathomechanisms of migraine is well described. The aim of this study was to evaluate the pattern of interleukin IL-۱β , IL -۱۷A, TAC and MDA in the migraine patients.methods: In this case-control study, serum samples were taken from ۳۱ migraine patients, who were referred to the neurology clinics of medical centers of Arak University of Medical Sciences. The severity of headache was assessed with standard questionnaires. Serum samples were also obtained from ۳۰normal individuals. The levels of IL -۱β and IL -۱۷A were measured by a sensitive ELISA method. Total antioxidant capacity ) TAC (was measured by FRAP technique, also lipid peroxidation level was evaluated by the MDA assay. Data was analyzed descriptively and analytically by SPSS۲۱ software.Results: The results showed that the mean level of IL-۱β in the case group was significantly higher than the control group (p =۰.۰۱). The mean level of IL-۱۷A was not significantly different in the two groups. Mean serum MDA level in the study group was significantly higher than in the controls (P=۰.۰۰۵). No statistical difference was observed in mean serum level of TAC between two groupsConclusion: It seems the pathogenesis of migraine can be associated with immune system function, and inhibition of pro-inflammatory cytokine production may be effective in the treatment of migraine patients.

نویسندگان

Mana Shojapour

Molecular and Medical Research Center, Arak University of Medical Sciences, Arak, Iran

Fardin Faraji

Department of Neurology, School of Medicine, Arak University of Medical Sciences, Arak, Iran.

Ghasem Mosayebi

Molecular and Medical Research Center, Arak University of Medical Sciences, Arak, Iran

Hossein Ansari

Department of Neurology, University of California, San Diego, USA

Afsoon Talaei

Department of Health and Nutrition, Islamic Azad University Arak Branch, Arak, Iran.

Fatemeh Rafiei

Biostatistician, Departmanof Biostatistics, Endocrinology and Metabolism Research Center, Arak University of Medical Sciences, Arak, Iran.

Mobina Ravanbakhsh

Student research committee, Arak University of Medical Sciences, Arak, Iran